PRS12 The Budgetary IMPACT of Introducing an Inactivated Influenza Vaccine for the Immunization of Adult Patients with Comorbidities, Covered By Private Insurance in Dubai

2021 ◽  
Vol 24 ◽  
pp. S215
Author(s):  
M. Farghally ◽  
B. Mahboub ◽  
M.A. Sara Ahmad ◽  
S. Shukla ◽  
O. Mohamed
2007 ◽  
Vol 13 (3) ◽  
pp. 307-313 ◽  
Author(s):  
Marika K. Iwane ◽  
James A. Singleton ◽  
Kimp Walton ◽  
Charmaine Coulen ◽  
Karen Wooten

2019 ◽  
Vol 37 (27_suppl) ◽  
pp. 71-71
Author(s):  
E. Bridget Kim ◽  
Mark Zangardi ◽  
Leila Rostamnjad ◽  
Ryan David Nipp ◽  
Mimi Bartholomay ◽  
...  

71 Background: Annual influenza vaccination is recommended for individuals 6 months and older. Older adults are at high-risk of developing influenza and complications associated with the virus. However, < 50% of patients with cancer receive the influenza vaccine annually. In previous work at our institution, a quality improvement project identified that only 40% of adult patients initiating parenteral anticancer therapy between September and December 2017 were documented to have received the influenza vaccine. Therefore, a multidisciplinary student pharmacist-directed pilot intervention was developed to improve influenza vaccine documentation and administration rates, and we sought to investigate the impact of this intervention. Methods: All adult patients (≥65 years old) scheduled for parenteral anticancer therapy during November 2018 were screened for influenza vaccination documentation. Patients were identified by reviewing infusion center schedule. Under supervision of board-certified oncology pharmacists, two student pharmacists evaluated influenza vaccination documentation in the institution/network electronic medical record (EMR) and outside records. Patients with unknown vaccination history were identified for interview by pharmacy students. The student pharmacists collaborated with oncology nurses and clinicians to order and administer influenza vaccine to patients who agreed to vaccination. Influenza vaccination status was updated in the EMR following record reviews/interviews. Results: Student pharmacists screened 617 patient EMRs and interviewed 124 patients to verify vaccination status. Furthermore, 33 patients received influenza vaccination as a direct result of student pharmacist intervention. Overall, rate of influenza vaccination status documentation was 60.5%. Conclusions: Compared with historic data, we found promising results for a student pharmacist-directed pilot intervention, which demonstrated the potential to improve influenza vaccination status documentation and administration among older adults receiving parenteral anticancer therapy.


Hypertension ◽  
2012 ◽  
Vol 60 (suppl_1) ◽  
Author(s):  
Madhuri Nair ◽  
Joshua R Thomas ◽  
Gopal Chandrasekharan ◽  
Yan D Zhao ◽  
Mark D Fox

BACKGROUND: Blood pressure (BP) screening in adults has been identified by the US Preventive Services Task Force as a Grade A recommendation. OBJECTIVE: To compare BP screening rates in adult patients among payer sources and provider types in two national probability samples of outpatient office visits. DESIGN/METHODS: An analysis of visit data for all patients 18 years and older in the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey-Outpatient Department (OPD) during the years 2005-2009 was performed. Data on 279,510 patient visits were analyzed, including adults seen in ambulatory or office-based settings (NAMCS, N=147,675) and hospital outpatient departments (OPD, N=131,835). BP screening rates were compared based on provider type (Family Practice, Internal Medicine, Obstetrics-Gynecology, and Cardiovascular Specialist) and payer source (Private Insurance, Medicare, Medicaid, and Self Pay). Results: Overall, BP screening rates were higher in the OPD sample (65.70% vs, 55.83%, p < .001), despite a higher mean age and higher proportion of privately insured or Medicare patients in the NAMCS sample. The odds ratio for BP screening was 1.538 for insured patients compared to self-pay in the NAMCS sample (95% CI: 1.473-1.606); however, the disparity was not observed in the OPD data. Cardiovascular specialists demonstrated the most adherence to BP screening, regardless of payer source. Overall BP screening rates are shown in Table 1. Conclusions: Analysis of two national probability samples reflected marked disparity in BP screening in adult patients based on payer source and provider type.


Blood ◽  
2016 ◽  
Vol 128 (22) ◽  
pp. 4858-4858
Author(s):  
Samip Master ◽  
Richard Preston Mansour

Introduction: Iron overload in adult patients with sickle cell disease (SCD) can lead to variety of complications like liver dysfunction/cirrhosis, cardiac enlargement, diabetes mellitus, hypogonadism and arthropathy. These complication can be prevented by iron chelation therapy .We did retrospective analysis to find incidence of iron over load in this population and also did a survey to find the insurance status in this population. Methods: We take care of approximately 300 adult patients with SCD at out hematology clinic. We did retrospective analysis to investigate the prevalence of iron overload in this population. We also did survey on 100 adult patients with SCD to find out about the insurance converge for them. Web search was done to find out the average monthly cost of iron chelators. Results: On retrospective analysis of 458 adult patients with SCD, we found that 117/458(25.58%) had iron over load. Majority of them, 93/117 were SS type of SCD. Results of survey done on 100 adult patients with SCD showed that 61 had Medicaid, 2 were free care, 25 had Medicare and 12 had private insurance. The average monthly cost of Deferiprone is $ 18762, while that of Deferasirox is $ 13,082. Conclusions: Iron over load is a common complication affecting a quarter of the adult patients with SCD. The treatment of iron overload is expensive, as just the iron-chelator therapy costs approximately 160 to 220 K per year. In an attempt to minimize additional iron accumulation in our chronically transfused patient population we encourage the schedule of exchange of 1 unit phlebotomy and 1 unit of red cell infusion every two weeks. Disclosures No relevant conflicts of interest to declare.


Vaccine ◽  
2012 ◽  
Vol 30 (5) ◽  
pp. 821-824 ◽  
Author(s):  
Sélilah Amour ◽  
Nicolas Voirin ◽  
Corinne Regis ◽  
Maude Bouscambert-Duchamp ◽  
Brigitte Comte ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document